Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors
Meric-Bernstam, F., Gutierrez, M., Sanz-Garcia, E., Villa, D., Zhang, J., Friedmann, J., Yan, F., Socinski, M. A., Sarantopoulos, J., Raez, L. E., Chu, Q. S., Chénard-Poirier, M., Chatterjee, M. S., Ren, H., Liu, Q., Levine, D. A. & Jhaveri, K. L., Jan 2025, In: Cancer Research Communications. 5, 9, p. 1664-1673 10 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Pilot phase II study of the combination of lenvatinib (L) and eribulin (E) in advanced solid tumors
Banwait, R., Ko, H., Michalek, J., Liu, Q., Lathrop, K., Bowhay-Carnes, E., Fotopoulos, G., Sarantopoulos, J., Elledge, R. M., Taverna, J., Karnad, A., Siziopikou, K. P. & Kaklamani, V., Aug 15 2025, In: International Journal of Cancer. 157, 4, p. 752-759 8 p.Research output: Contribution to journal › Article › peer-review
-
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies
Lin, C. C., Garralda, E., Schöffski, P., Hong, D. S., Siu, L. L., Martin, M., Maur, M., Hui, R., Soo, R. A., Chiu, J., Zhang, T., Ma, B., Kyi, C., Tan, D. S. W., Cassier, P. A., Sarantopoulos, J., Weickhardt, A., Carvajal, R. D., Spratlin, J. & Esaki, T. & 10 others, , 2024, In: OncoImmunology. 13, 1, 2290787.Research output: Contribution to journal › Article › peer-review
Open Access24 Link opens in a new tab Scopus citations -
Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer
Mahalingam, D., Hanni, S., Serritella, A. V., Fountzilas, C., Michalek, J., Hernandez, B., Sarantopoulos, J., Datta, P., Romero, O., Pillai, S. M. A., Kuhn, J., Pollak, M. & Thompson, I. M., 2023, In: Oncotarget. 14, 1, p. 622-636 15 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Link opens in a new tab Scopus citations -
A First-in-Human, Phase I, Multicenter, Open-Label, Dose-Escalation Study of PCA062: An Antibody-Drug Conjugate Targeting P-Cadherin, in Patients With Solid Tumors
Duca, M., Lim, D. W. T., Subbiah, V., Takahashi, S., Sarantopoulos, J., Varga, A., D'Alessio, J. A., Abrams, T., Sheng, Q., Tan, E. Y., Rosa, M. S., Gonzalez-Maffe, J., Sand-Dejmek, J., Fabre, C. & Martin, M., Apr 2022, In: Molecular cancer therapeutics. 21, 4, p. 625-634 10 p.Research output: Contribution to journal › Article › peer-review
14 Link opens in a new tab Scopus citations
Datasets
-
Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer
Tsimberidou, A.-M. (Creator), Shaw, J. V. (Creator), Juric, D. (Creator), Verschraegen, C. (Creator), Weise, A. M. (Creator), Sarantopoulos, J. (Creator), Lopes, G. (Creator), Nemunaitis, J. (Creator), Mita, M. (Creator), Park, H. (Creator), Ellers-Lenz, B. (Creator), Tian, H. (Creator), Xiong, W. (Creator), Kaleta, R. (Creator) & Kurzrock, R. (Creator), Figshare, 2021
DOI: 10.6084/m9.figshare.c.5568537.v1, https://springernature.figshare.com/collections/Phase_1_study_of_M2698_a_p70S6K_AKT_dual_inhibitor_in_patients_with_advanced_cancer/5568537/1
Dataset
-
Pharmacokinetics of carfilzomib in patients with advanced malignancies and varying degrees of hepatic impairment: an open-label, single-arm, phase 1 study
Brown, J. (Creator), Plummer, R. (Creator), Bauer, T. M. (Creator), Anthony, S. (Creator), Sarantopoulos, J. (Creator), Vos, F. (Creator), White, M. (Creator), Schupp, M. (Creator), Ou, Y. (Creator) & Vaishampayan, U. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3895900.v1, https://figshare.com/collections/Pharmacokinetics_of_carfilzomib_in_patients_with_advanced_malignancies_and_varying_degrees_of_hepatic_impairment_an_open-label_single-arm_phase_1_study/3895900/1
Dataset
-
Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer
Tsimberidou, A.-M. (Creator), Shaw, J. V. (Creator), Juric, D. (Creator), Verschraegen, C. (Creator), Weise, A. M. (Creator), Sarantopoulos, J. (Creator), Lopes, G. (Creator), Nemunaitis, J. (Creator), Mita, M. (Creator), Park, H. (Creator), Ellers-Lenz, B. (Creator), Tian, H. (Creator), Xiong, W. (Creator), Kaleta, R. (Creator) & Kurzrock, R. (Creator), Figshare, 2021
DOI: 10.6084/m9.figshare.c.5568537, https://springernature.figshare.com/collections/Phase_1_study_of_M2698_a_p70S6K_AKT_dual_inhibitor_in_patients_with_advanced_cancer/5568537
Dataset
-
Pharmacokinetics of carfilzomib in patients with advanced malignancies and varying degrees of hepatic impairment: an open-label, single-arm, phase 1 study
Brown, J. (Creator), Plummer, R. (Creator), Bauer, T. M. (Creator), Anthony, S. (Creator), Sarantopoulos, J. (Creator), Vos, F. (Creator), White, M. (Creator), Schupp, M. (Creator), Ou, Y. (Creator) & Vaishampayan, U. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3895900, https://figshare.com/collections/Pharmacokinetics_of_carfilzomib_in_patients_with_advanced_malignancies_and_varying_degrees_of_hepatic_impairment_an_open-label_single-arm_phase_1_study/3895900
Dataset